Studies related to Migraine and Vitamin B2

Riboflavin Prophylaxis In Pediatric And Adolescent Migraine

Effect Decrease
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 41
Sex Both Genders
Age Range 7-12, 13-17
Notes for this study:
Supplementation of riboflavin in youth (pediatric and adolescent subjects) at either 200mg or 400mg a day over the course of 3-6 months appeared to be beneficial in improving symptoms of migraines.

The amount of subjects in the riboflavin group reported more than a halving of migraine frequency reached 68.4%, whereas average intensity reported from migraines was reduced 21% compared to baseline (no significant change noted with placebo).

Full details on all 7 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.